Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 12, 2026
Greg Harrison's Stock Ratings
B of A Securities Analyst
Greg Harrison is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
63.9%
Smart Score
Overall Average Return Percentile
95th
Number of Ratings
100
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/10/2026 | UTHR | Buy Now | United Therapeutics | $549.16 | 11.63% | $620 → $613 | Maintains | Neutral | Get Alert | |
| 05/29/2026 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 25.75% | $41 → $40 | Maintains | Buy | Get Alert | |
| 04/21/2026 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 28.89% | $44 → $41 | Maintains | Buy | Get Alert | |
| 03/31/2026 | UTHR | Buy Now | United Therapeutics | $549.16 | 13.99% | $569 → $626 | Maintains | Neutral | Get Alert | |
| 03/13/2026 | MLYS | Buy Now | Mineralys Therapeutics | $23.30 | 118.84% | $46 → $51 | Maintains | Buy | Get Alert | |
| 02/13/2026 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.00 | 9.41% | $495 → $558 | Maintains | Sector Perform | Get Alert | |
| 12/24/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 6.88% | $32 → $34 | Maintains | Buy | Get Alert | |
| 11/20/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 0.6% | $54 → $32 | Maintains | Buy | Get Alert | |
| 10/27/2025 | NTLA | Buy Now | Intellia Therapeutics | $12.96 | 131.48% | $36 → $30 | Maintains | Buy | Get Alert | |
| 09/02/2025 | UTHR | Buy Now | United Therapeutics | $549.16 | -15.69% | $314 → $463 | Maintains | Neutral | Get Alert | |
| 08/28/2025 | MLYS | Buy Now | Mineralys Therapeutics | $23.30 | 84.52% | $38 → $43 | Maintains | Buy | Get Alert | |
| 08/07/2025 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -40.53% | $30 → $31 | Maintains | Sector Outperform | Get Alert | |
| 08/06/2025 | OCUL | Buy Now | Ocular Therapeutix | $7.59 | 163.51% | $22 → $20 | Maintains | Sector Outperform | Get Alert | |
| 08/06/2025 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -12.78% | $55 → $57 | Maintains | Sector Outperform | Get Alert | |
| 08/05/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.00 | -14.12% | $442 → $438 | Maintains | Sector Perform | Get Alert | |
| 08/01/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | 93.47% | $342 → $450 | Maintains | Sector Outperform | Get Alert | |
| 07/28/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 104.34% | $71 → $65 | Maintains | Sector Outperform | Get Alert | |
| 07/22/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 60.33% | $52 → $51 | Maintains | Buy | Get Alert | |
| 07/14/2025 | GOSS | Buy Now | Gossamer Bio | $9.47 | 16.16% | → $11 | Initiates | → Sector Outperform | Get Alert | |
| 07/02/2025 | ARCT | Buy Now | Arcturus Therapeutics | $13.84 | 152.89% | $32 → $35 | Maintains | Sector Outperform | Get Alert | |
| 06/11/2025 | UTHR | Buy Now | United Therapeutics | $549.16 | -42.64% | $321 → $315 | Maintains | Neutral | Get Alert | |
| 06/02/2025 | VERA | Buy Now | Vera Therapeutics | $29.88 | 117.54% | $55 → $65 | Maintains | Sector Outperform | Get Alert | |
| 05/28/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.54 | 648.03% | $51 → $19 | Maintains | Sector Outperform | Get Alert | |
| 05/28/2025 | LQDA | Buy Now | Liquidia | $28.56 | 29.53% | $36 → $37 | Maintains | Sector Outperform | Get Alert | |
| 05/28/2025 | ARCT | Buy Now | Arcturus Therapeutics | $13.84 | 131.21% | → $32 | Initiates | → Sector Outperform | Get Alert | |
| 05/12/2025 | VERA | Buy Now | Vera Therapeutics | $29.88 | 84.07% | $60 → $55 | Maintains | Sector Outperform | Get Alert | |
| 05/12/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.54 | 1907.87% | $52 → $51 | Maintains | Sector Outperform | Get Alert | |
| 05/12/2025 | KROS | Buy Now | Keros Therapeutics | $11.95 | 117.57% | $41 → $26 | Maintains | Sector Outperform | Get Alert | |
| 05/08/2025 | APLS | Buy Now | Apellis Pharmaceuticals | — | — | $28 → $20 | Maintains | Sector Perform | Get Alert | |
| 05/08/2025 | GERN | Buy Now | Geron | $1.23 | 21.95% | $4 → $1.5 | Downgrade | Sector Outperform → Sector Perform | Get Alert | |
| 05/06/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.00 | -13.33% | $450 → $442 | Maintains | Sector Perform | Get Alert | |
| 05/05/2025 | LQDA | Buy Now | Liquidia | $28.56 | 26.03% | $34 → $36 | Maintains | Sector Outperform | Get Alert | |
| 05/02/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 123.2% | $74 → $71 | Maintains | Sector Outperform | Get Alert | |
| 05/01/2025 | UTHR | Buy Now | United Therapeutics | $549.16 | -41.55% | $314 → $321 | Maintains | Neutral | Get Alert | |
| 04/30/2025 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -15.84% | $52 → $55 | Maintains | Sector Outperform | Get Alert | |
| 04/21/2025 | UTHR | Buy Now | United Therapeutics | $549.16 | -42.82% | $314 → $314 | Upgrade | Underperform → Neutral | Get Alert | |
| 04/02/2025 | APLS | Buy Now | Apellis Pharmaceuticals | — | — | $30 → $31 | Maintains | Sector Perform | Get Alert | |
| 03/31/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | 47.03% | $338 → $342 | Maintains | Sector Outperform | Get Alert | |
| 03/21/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | 45.31% | $300 → $338 | Maintains | Sector Outperform | Get Alert | |
| 03/20/2025 | LQDA | Buy Now | Liquidia | $28.56 | 19.03% | $30 → $34 | Maintains | Sector Outperform | Get Alert | |
| 03/10/2025 | BEAM | Buy Now | Beam Therapeutics | $25.70 | 55.64% | → $40 | Upgrade | Sector Perform → Sector Outperform | Get Alert | |
| 03/03/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.54 | 1947.24% | $51 → $52 | Maintains | Sector Outperform | Get Alert | |
| 03/03/2025 | IRON | Buy Now | Disc Medicine | $62.06 | 20.85% | $73 → $75 | Maintains | Sector Outperform | Get Alert | |
| 03/03/2025 | BEAM | Buy Now | Beam Therapeutics | $25.70 | -2.72% | $24 → $25 | Maintains | Sector Perform | Get Alert | |
| 02/27/2025 | GERN | Buy Now | Geron | $1.23 | 225.2% | $6 → $4 | Maintains | Sector Outperform | Get Alert | |
| 02/21/2025 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -20.43% | $49 → $52 | Maintains | Sector Outperform | Get Alert | |
| 02/14/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | 28.98% | $310 → $300 | Maintains | Sector Outperform | Get Alert | |
| 02/12/2025 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -38.61% | $27 → $32 | Maintains | Sector Outperform | Get Alert | |
| 02/12/2025 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -25.02% | $48 → $49 | Maintains | Sector Outperform | Get Alert | |
| 02/11/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.00 | -11.76% | $433 → $450 | Maintains | Sector Perform | Get Alert | |
| 01/31/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.00 | -15.1% | $430 → $433 | Maintains | Sector Perform | Get Alert | |
| 01/22/2025 | IRON | Buy Now | Disc Medicine | $62.06 | 17.63% | $70 → $73 | Maintains | Sector Outperform | Get Alert | |
| 01/16/2025 | KROS | Buy Now | Keros Therapeutics | $11.95 | 243.1% | $44 → $41 | Maintains | Sector Outperform | Get Alert | |
| 12/23/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.00 | -15.69% | $426 → $430 | Maintains | Sector Perform | Get Alert | |
| 12/13/2024 | KROS | Buy Now | Keros Therapeutics | $11.95 | 268.2% | $77 → $44 | Maintains | Sector Outperform | Get Alert | |
| 12/09/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 135.77% | $53 → $75 | Maintains | Sector Outperform | Get Alert | |
| 12/03/2024 | KROS | Buy Now | Keros Therapeutics | $11.95 | 544.35% | $76 → $77 | Maintains | Buy | Get Alert | |
| 11/25/2024 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -26.55% | $45 → $48 | Maintains | Sector Outperform | Get Alert | |
| 11/15/2024 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -31.14% | $44 → $45 | Maintains | Sector Outperform | Get Alert | |
| 11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | — | — | $35 → $30 | Maintains | Sector Perform | Get Alert | |
| 11/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.00 | -4.71% | $480 → $486 | Maintains | Sector Perform | Get Alert | |
| 11/05/2024 | IRON | Buy Now | Disc Medicine | $62.06 | 12.79% | $62 → $70 | Maintains | Sector Outperform | Get Alert | |
| 11/01/2024 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -48.2% | $23 → $27 | Maintains | Sector Outperform | Get Alert | |
| 11/01/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | 33.28% | $305 → $310 | Maintains | Sector Outperform | Get Alert | |
| 11/01/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 66.61% | $51 → $53 | Maintains | Sector Outperform | Get Alert | |
| 10/16/2024 | IRON | Buy Now | Disc Medicine | $62.06 | -0.1% | → $62 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -55.88% | → $23 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.00 | -5.88% | → $480 | Initiates | → Sector Perform | Get Alert | |
| 10/16/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | 31.13% | → $305 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | APLS | Buy Now | Apellis Pharmaceuticals | — | — | → $35 | Initiates | → Sector Perform | Get Alert | |
| 10/16/2024 | VERA | Buy Now | Vera Therapeutics | $29.88 | 100.8% | → $60 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | KROS | Buy Now | Keros Therapeutics | $11.95 | 544.35% | → $77 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $3.38 | 432.54% | → $18 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | BEAM | Buy Now | Beam Therapeutics | $25.70 | -6.61% | → $24 | Initiates | → Sector Perform | Get Alert | |
| 10/16/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $31.81 | 60.33% | → $51 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | LQDA | Buy Now | Liquidia | $28.56 | 5.03% | → $30 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | GERN | Buy Now | Geron | $1.23 | 387.8% | → $6 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.54 | 1868.5% | → $50 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | OCUL | Buy Now | Ocular Therapeutix | $7.59 | 189.86% | → $22 | Initiates | → Sector Outperform | Get Alert | |
| 10/16/2024 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -32.67% | → $44 | Initiates | → Sector Outperform | Get Alert | |
| 08/01/2024 | UTHR | Buy Now | United Therapeutics | $549.16 | -49.01% | $303 → $280 | Maintains | Underperform | Get Alert | |
| 12/21/2023 | LQDA | Buy Now | Liquidia | $28.56 | -47.49% | $13 → $15 | Maintains | Buy | Get Alert | |
| 12/15/2023 | BEAM | Buy Now | Beam Therapeutics | $25.70 | 36.19% | → $35 | Downgrade | Buy → Neutral | Get Alert | |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -48.2% | $41 → $27 | Maintains | Buy | Get Alert | |
| 07/26/2023 | KROS | Buy Now | Keros Therapeutics | $11.95 | 443.93% | → $65 | Initiates | → Buy | Get Alert | |
| 06/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $12.96 | 602.16% | $89 → $91 | Maintains | Buy | Get Alert | |
| 05/02/2023 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -25.18% | $52 → $39 | Maintains | Buy | Get Alert | |
| 05/01/2023 | STOK | Buy Now | Stoke Therapeutics | $24.00 | -50% | $9 → $12 | Upgrade | Underperform → Neutral | Get Alert | |
| 04/28/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.07 | 1927.03% | $5 → $1.5 | Downgrade | Neutral → Underperform | Get Alert | |
| 03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $23.30 | 67.35% | → $39 | Initiates | → Buy | Get Alert | |
| 12/23/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.54 | 1277.95% | $38 → $35 | Maintains | Buy | Get Alert | |
| 11/18/2022 | EDIT | Buy Now | Editas Medicine | $3.00 | 400.02% | $18 → $15 | Maintains | Neutral | Get Alert | |
| 11/08/2022 | OMER | Buy Now | Omeros | $19.74 | -84.8% | → $3 | Downgrade | Neutral → Underperform | Get Alert | |
| 09/29/2022 | EDIT | Buy Now | Editas Medicine | $3.00 | 500.02% | → $18 | Initiates | → Neutral | Get Alert | |
| 09/29/2022 | SNTI | Buy Now | Senti Biosciences | $0.31 | 2152.25% | → $7 | Initiates | → Buy | Get Alert | |
| 09/12/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | → $1 | Downgrade | Buy → Underperform | Get Alert | |
| 06/16/2022 | NTLA | Buy Now | Intellia Therapeutics | $12.96 | 440.12% | → $70 | Initiates | → Buy | Get Alert | |
| 06/08/2022 | RDUS | Buy Now | Radius Health | — | — | → $8 | Upgrade | Underperform → Neutral | Get Alert | |
| 06/08/2022 | ISEE | Buy Now | IVERIC bio | — | — | → $18 | Initiates | → Buy | Get Alert | |
| 05/26/2022 | LQDA | Buy Now | Liquidia | $28.56 | -57.99% | → $12 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved